Apr 16 |
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
|
Apr 14 |
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
|
Apr 10 |
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
|
Apr 7 |
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
|
Apr 1 |
Rhythm Pharmaceuticals gets $150M in convertible preferred stock financing
|
Apr 1 |
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
|
Mar 25 |
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
|
Mar 22 |
Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
Mar 20 |
Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares
|
Mar 20 |
Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...
|